Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Galtier

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Frontiers in Psychology|May 13, 2021
BeatWalk: Personalized Music-Based Gait Rehabilitation in Parkinson's DiseaseValérie Cochen De Cock, Dobromir Dotov, Loic Damm, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
Scientific Reports|March 11, 2022
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter studyDavid Luque-Paz, Pierre Tattevin, Paul Loubet, et al.
Influenza and Other Respiratory Viruses|February 6, 2020
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela M C Rose, Esther Kissling, Alin Gherasim, et al.
The Journal of Infectious Diseases|February 1, 2014
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessAnn R Falsey, Janet E McElhaney, Jiri Beran, et al.
Human Vaccines & Immunotherapeutics|October 4, 2016
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysisGuillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyOdile Launay, Vered Abitbol, Anne Krivine, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
The Lancet. Rheumatology|August 1, 2025
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trialJacques Morel, Emmanuelle Dernis, Christian Roux, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Frontiers in Psychology|May 13, 2021
BeatWalk: Personalized Music-Based Gait Rehabilitation in Parkinson's DiseaseValérie Cochen De Cock, Dobromir Dotov, Loic Damm, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
Scientific Reports|March 11, 2022
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter studyDavid Luque-Paz, Pierre Tattevin, Paul Loubet, et al.
Influenza and Other Respiratory Viruses|February 6, 2020
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela M C Rose, Esther Kissling, Alin Gherasim, et al.
The Journal of Infectious Diseases|February 1, 2014
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessAnn R Falsey, Janet E McElhaney, Jiri Beran, et al.
Human Vaccines & Immunotherapeutics|October 4, 2016
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysisGuillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyOdile Launay, Vered Abitbol, Anne Krivine, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
The Lancet. Rheumatology|August 1, 2025
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trialJacques Morel, Emmanuelle Dernis, Christian Roux, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
Pageof 8